Clinical Trials Browser

Phase 3 × Thoracic Neoplasms × Gefitinib × Clear all

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Phase 3 Completed

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms